122 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Cell line)

« prev | Page of 3 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
JUNJun proto-oncogeneCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Transcription factors
Expressed in all
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK9Potassium channel, subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KEAP1Kelch-like ECH-associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAP4Microtubule-associated protein 4FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Not detected
MTR5-methyltetrahydrofolate-homocysteine methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
NFKB1Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Transcription factors
Expressed in all
NR3C1Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
PDE3APhosphodiesterase 3A, cGMP-inhibitedEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
PDXKPyridoxal (pyridoxine, vitamin B6) kinaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PLA2G4APhospholipase A2, group IVA (cytosolic, calcium-dependent)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Mixed
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
POLA1Polymerase (DNA directed), alpha 1, catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
POLEPolymerase (DNA directed), epsilon, catalytic subunitCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
POLE2Polymerase (DNA directed), epsilon 2, accessory subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
PPARGPeroxisome proliferator-activated receptor gammaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Expressed in all
PRKAA1Protein kinase, AMP-activated, alpha 1 catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
PRKAB1Protein kinase, AMP-activated, beta 1 non-catalytic subunitFDA approved drug targets
Predicted intracellular proteins
Expressed in all
PSMB1Proteasome (prosome, macropain) subunit, beta type, 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB10Proteasome (prosome, macropain) subunit, beta type, 10Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB2Proteasome (prosome, macropain) subunit, beta type, 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB5Proteasome (prosome, macropain) subunit, beta type, 5Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB9Proteasome (prosome, macropain) subunit, beta type, 9Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PTGS1Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
RARARetinoic acid receptor, alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transcription factors
Expressed in all
RARBRetinoic acid receptor, betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Mixed
RARGRetinoic acid receptor, gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Tissue enhanced
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Ribosomal proteins
Expressed in all
RRM1Ribonucleotide reductase M1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
RRM2Ribonucleotide reductase M2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
RRM2BRibonucleotide reductase M2 B (TP53 inducible)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
RXRARetinoid X receptor, alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
RXRBRetinoid X receptor, betaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
SCNN1DSodium channel, non-voltage-gated 1, delta subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
SHMT1Serine hydroxymethyltransferase 1 (soluble)Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all

« prev | Page of 3 | next »